Good Practices For Pharmaceutical
Quality Control Laboratories
F o u a d A s h r a f – E D A , M i c r o b i o l o g y L a b o r a t o r y E l - A g o u z a
1
General Considerations
• These guidelines are applicable to any
pharmaceutical quality control laboratory, be it
national, commercial or nongovernmental.
• However, they do not include guidance for those
laboratories involved in the testing of biological
products (e.g., vaccines and blood products),
separate guidance for such laboratories is
available.
2
• National pharmaceutical quality control laboratories usually
encompass essentially two types of activity:
a. Compliance testing of APIs, pharmaceutical excipients
and pharmaceutical products employing official
pharmacopeial methods.
b. Investigative testing of suspicious, illegal, counterfeit
substances or products, submitted for examination by
medicine inspectors, customs or police.
• Note: To ensure patient safety, the role of the national
pharmaceutical quality control laboratory should be
defined in the general pharmaceutical legislation of the
country in such a way that the results provided by it can, if
necessary, lead to enforcement of the law and legal action.
3
Good Laboratory Practice
I. Management and Infrastructure
II. Materials, Equipment, Instruments
and Other Devices
III. Working Procedures
IV. Safety
4
Management and Infrastructure
Part One
5
• The laboratory should be legally authorized to function and can be held legally responsible.
• The laboratory should be organized and operate so as to meet the requirements laid down in these
guidelines.
• The laboratory should:
a. Have managerial and technical personnel with the authority and resources needed to carry out their
duties, and to identify the occurrence of departures from the quality management system.
b. Have arrangements to ensure that its management and personnel are not subject to commercial,
political, financial and other pressures or conflicts of interest that may adversely affect the quality of
their work.
c. Designate a member of staff as Quality Manager, who, irrespective of other duties they may have, will
ensure compliance with the quality management system. The nominated quality manager should have
direct access to the highest level of management at which decisions are taken on laboratory policies or
resources.
1- Organization & Management
6
d. Have a policy in place to ensure confidentiality of information, transfer of results and reports, data in
archives.
e. Define its place in any parent organization and the relationships between management, technical
operations and support services.
f. Ensure the precise allocation of responsibilities.
g. Provide adequate supervision of staff, including trainees.
h. Ensure adequate information flow between staff at all levels.
i. Ensure the traceability of the sample from receipt, throughout the stages of testing, to the completion
of the analytical test report.
• The laboratory should maintain a registry with the following functions:
a. Keeping records on all incoming samples and accompanying documents.
b. Distributing and supervising the consignment of the samples to the specific units.
• In a large laboratory, it is necessary to guarantee communication and coordination between the staff
involved in the testing of the same sample in different units.
7
2- Quality Management System
 The laboratory management should establish, implement and maintain a quality management system
appropriate to the scope of its activities, including the type and volume of testing and the calibration,
validation and verification activities it undertakes.
 The documentation used in this quality management system should be communicated, available to, and
understood and implemented by, the appropriate personnel.
 The elements of this system should be documented in a quality manual, for the organization as a whole or for
the laboratory within the organization.
 The quality manual should contain as a minimum:
a. A quality policy statement including:
i. A statement of the laboratory management’s intentions with respect to the service it will provide.
ii. The laboratory management’s commitment to good professional practice and quality of testing,
calibration and validation.
iii. A requirement that all personnel concerned with testing and calibration activities within the
laboratory familiarize themselves with the documentation concerning quality and the implementation
of the policies and procedures in their work. 8
b. The structure of the laboratory (organizational chart).
c. References to specific procedures for each test.
d. Information on the appropriate qualifications and experience that personnel are required to possess.
e. Information on initial and in-service training of staff.
f. A policy for internal and external audit.
g. A policy for implementing and verifying corrective and preventive actions.
h. A policy for dealing with complaints.
i. A policy for selecting and approving analytical procedures.
j. A policy for handling of out of specification (OOS) results.
k. A policy for the employment of appropriate reference substances and reference materials.
l. A policy to select service providers and suppliers.
 The laboratory should implement and maintain authorized written SOPs, including but not limited to:
a. Personnel training, clothing and hygiene.
b. Internal audit.
c. Dealing with complaints.
d. Implementation corrective and preventive actions. 9
e. The purchase and receipt of consignments of materials (e.g., samples, media, reagents).
f. Obtainment, preparation and control of reference substances and reference materials.
g. The internal labelling and storage of materials.
h. The qualification of equipment.
i. The calibration of equipment.
j. The testing of samples with descriptions of the methods and equipment used.
k. Atypical and OOS results.
l. Validation of analytical procedures.
m.Cleaning of laboratory facilities, including bench tops, equipment, work stations, clean rooms and
glassware.
n. Monitoring of environmental conditions (e.g., temperature and humidity); monitoring of storage
conditions.
o. Disposal of reagents and solvent samples.
p. Safety measures.
10
 The activities of the laboratory should be systematically and periodically audited, internally and by external
audits, to verify compliance with the requirements of the quality management system and to apply
corrective and preventive actions, if necessary.
 Management review of quality issues should be undertaken annually, and it includes:
a. Reports on internal and external audits.
b. The outcome of investigations carried out as a result of complaints received, doubtful, atypical or
aberrant results reported.
c. Corrective actions applied and preventive actions introduced as a result of these investigations.
11
3- Control of Documentation
 Documentation is an essential part of the quality management system; The laboratory should establish and
maintain procedures to control and review all documents (both internally generated and from external
sources).
 The procedures should ensure that:
a. Each document, technical or quality, has a unique identifier, version number and date of implementation.
b. Appropriate, authorized SOPs are available at the relevant locations (e.g., near instruments).
c. Documents are kept up to date and reviewed as required; any invalid document is removed and replaced
with the authorized, revised version.
d. A revised document includes references to the previous document.
e. Old, invalid documents are retained in the archives to ensure traceability of the evolution of the
procedures; copies are destroyed.
f. All relevant staff are trained for the new and revised SOPs.
g. Quality documentation, including records, is retained for a minimum of five years. 12
 A system of change control should be in place to inform staff of new and revised procedures. The system
should ensure that:
a. Revised documents are 1) prepared by a person who performs the same function 2) reviewed and
approved at the same level as the original document.
b. Staff acknowledge by a signature that they are aware of applicable changes and their date of
implementation.
13
4- Records
 The laboratory should establish and maintain procedures for the identification, collection, indexing, retrieval,
storage, maintenance and disposal of and access to all quality, technical and scientific records.
 All original observations, including calculations and derived data, calibration, validation and verification
records and final results, should be retained on record for an appropriate period of time.
 The records should include the data recorded in the analytical worksheet by the technician or analyst on
consecutively numbered pages.
 The records should include the identity of the personnel involved in the testing of the samples.
 All records (including analytical test reports, certificates of analysis) should be legible, readily retrievable,
stored and retained within facilities that provide a suitable environment that will prevent modification,
damage, deterioration or loss. And as to ensure their security and confidentiality.
14
5- Data-processing Equipment
 For computers, automated tests or calibration equipment, and the collection, processing, recording,
reporting, storage or retrieval of the data they produce, the laboratory should ensure that:
a. Computer software developed by the user is documented in sufficient detail and appropriately
validated or verified as being suitable for use.
b. Procedures are implemented for protecting the integrity and confidentiality of data.
c. Electronic data should be backed up at appropriate regular intervals according to a documented
procedure. Backed-up data should be retrievable and stored in such a manner as to prevent data loss.
15
6- Personnel
 The laboratory should have sufficient personnel with the necessary education, training, technical
knowledge and experience for their assigned functions.
 The technical management should ensure the competence of all personnel operating specific equipment,
instruments or other devices, who are performing tests or calibrations, validations or verifications. Their
duties also involve the evaluation of results as well as signing analytical test reports and certificates of
analysis.
 Staff undergoing training should be appropriately supervised and should be assessed on completion of the
training.
 The laboratory personnel should be permanently employed or under contract.
 The laboratory should maintain:
a. Current job descriptions for all personnel involved in tests, calibrations, validations and verifications.
b. Records of all technical personnel, describing their qualifications, training and experience.
16
 The laboratory should have the following managerial and technical personnel:
a. A Head of Laboratory (Supervisor) who is responsible for the content of certificates of analysis and
analytical testing reports, and is also responsible for ensuring that:
i. All key members of the laboratory staff have the necessary competence for the required functions
and responsibilities.
ii. The adequacy of existing staffing, management and training procedures is reviewed periodically.
iii.The technical management is adequately supervised.
b. A Quality Manager (see part one, point 3-c).
c. The Technical Management who ensure that:
i. Procedures for performing calibration, verification and requalification of instruments, monitoring of
environmental and storage conditions are in place and are conducted as required.
ii. Training programs to update and extend the skills of personnel are arranged.
iii.The safekeeping of any materials subject to poison regulation or to the controls applied to narcotic
and psychotropic substances kept in the workplace is under the supervision of an authorized
person. 17
iv. National pharmaceutical quality control laboratories regularly participate in suitable proficiency
testing schemes and collaborative trials to assess analytical procedures or reference substances.
d. Analysts, who should normally be graduates in Pharmacy, Analytical Chemistry, Microbiology or other
relevant subjects, with the requisite knowledge, skills and ability to adequately perform the tasks
assigned to them by management and to supervise technical staff.
e. Technical Staff, who should hold diplomas in their subjects awarded by technical or vocational schools.
18
7- Premises
 The laboratory facilities are to be of a suitable size, designed to suit the functions and operations to be
conducted in them.
 Changing areas and toilets should be easily accessible and appropriate for the number of users.
 The laboratory facilities should have adequate safety equipment located appropriately.
 The laboratory should be equipped with adequate instruments and equipment, including work benches and
stations.
 The environmental conditions, including lighting, energy sources, temperature, humidity and air pressure,
are to be appropriate to the functions and operations to be performed; these conditions are to be
documented.
 There should be a separate and dedicated unit or equipment (e.g., laminar flow workbench) to handle,
weigh and manipulate highly toxic substances; procedures should be in place to avoid exposure and
contamination.
19
 Archive facilities should be provided to ensure the secure storage and retrieval of all documents; Access to
the archives should be restricted to designated personnel.
 Tools/material should be in place for the safe removal of types of waste, including toxic waste (chemical
and biological), reagents, samples, solvents and air filters.
 Microbiological testing, if performed, should be contained in an appropriately designed and constructed
laboratory unit. (For further guidance see the document: WHO guideline on good practices for
pharmaceutical microbiology laboratories [reference QAS/09.297]).
 If in vivo biological testing (e.g., rabbit pyrogen test) is included in the scope of the laboratory activities,
then the animal houses should be isolated from the other laboratory areas with a separate entrance and
air-conditioning system.
20
 Laboratory storage facilities should:
a. Be well organized.
b. Be separate for the storage of samples, laboratory accessories, reference substances and reference
materials.
c. Have separate rooms or areas for storing flammable substances, fuming and concentrated acids and
bases, volatile amines and other reagents (e.g., hydrochloric acid, nitric acid, ammonia and bromine)
and Self-igniting materials (e.g., metallic sodium and potassium).
d. Be equipped to store material under refrigeration (2-8°C) and frozen (-20°C).
e. Have a dedicated storage area for gases, isolated from the main building if possible.
21
8- Equipment, Instruments and Other Devices
 The laboratory should have the required test equipment, instruments and other devices for the correct
performance of the tests, calibrations and validations.
 Equipment, instruments and other devices should be designed, constructed, adapted, located, calibrated,
qualified, verified and maintained as required by the operations to be carried out in the local environment.
 It should be purchased from an agent capable of providing full technical support and maintenance when
necessary.
22
9- Contracts
 Purchasing services and supplies:
a. The laboratory should have a procedure for the selection and purchasing of services and supplies it uses
that affect the quality of testing.
b. The laboratory should evaluate suppliers of critical consumables (e.g., Petri Dishes), maintain records of
these evaluations, list approved suppliers which have been demonstrated to be of suitable quality with
respect to the requirements of the laboratory.
 Subcontracting of testing:
a. When the laboratory subcontracts work, it is to be done with organizations approved for the type of
activity required.
b. When a laboratory performs testing for a customer and subcontracts part of the testing, it should advise
the customer of the arrangement in writing and gain their approval.
23
c. There should be a contract that permit the laboratory to audit the facilities and competencies of the
contracted organization and ensure the access of the laboratory to their records and retained
samples.
d. The contracted organization should not pass to a third party any work entrusted to it under contract
without the laboratory’s prior evaluation and approval of the arrangements.
e. The laboratory should maintain a register of all subcontractors that it uses, and a record of the
assessment of their competence.
f. The laboratory takes the responsibility for all results reported, including those furnished by the
subcontracting organization.
24
Materials, Equipment, Instruments
and Other Devices
Part Two
25
1- Reagents
 All reagents and chemicals used in tests and assays, should be of appropriate quality.
 Reagents should be purchased from reputable, approved suppliers and accompanied by the certificate of
analysis.
 Regarding preparation of reagent solutions in the laboratory:
a. Responsibility for this task should be clearly specified in the job description of the person assigned to
carry it out.
b. Pharmacopeial prescribed procedures should be used.
c. Records of the preparations should be kept.
 The labels of all reagents should clearly specify:
a. Content.
b. Manufacturer.
c. Date received and date of opening of the container.
d. Concentration, if applicable.
e. Storage conditions required.
f. Expiry date or retest date. 26
 The labels of reagents prepared in the laboratory should clearly specify:
a. Name.
b. Date of preparation and initials of technician or analyst.
c. Expiry date or retest date.
d. Concentration, if applicable.
 Regarding the transportation and subdivision of reagents:
a. They should be transported in the original containers.
b. When subdivision is necessary, clean and appropriately labelled containers should be used.
 Visual Inspection:
a. All reagent containers should be visually inspected to ensure that the seals are intact.
b. Reagents that appear to have been tampered with should be rejected; however, this may exceptionally
be waived if the identity and purity of the reagent concerned can be confirmed by testing.
27
 Water:
a. Water should be considered as a reagent.
b. Precautions should be taken to avoid contamination during its supply, storage and distribution.
c. The quality of the water should be verified regularly to ensure that the various grades of water meet
the appropriate specifications.
 Storage:
a. Stocks of reagents should be maintained under the appropriate storage conditions (e.g., ambient
temperature, under refrigeration or frozen).
b. The store should contain a supply of clean bottles, vials, spoons and funnels for dispensing reagents
from larger to smaller containers.
c. Special equipment may be needed for the transfer of larger volumes of corrosive liquids.
d. The person in charge of the store is responsible for the inventory and for noting the expiry date of
chemicals and reagents.
e. Training may be needed in handling chemicals safely and with the necessary care.
28
2- Reference Substances and Reference Materials
 Reference substances (primary and secondary) are used for the testing of a sample; Pharmacopeial reference
substances should be employed when available; When a pharmacopoeia reference substance has not been
established then the manufacturer should use its own reference substance.
 Reference materials may be necessary for the calibration and/or qualification of equipment, instruments or
other devices.
 Registration and labelling:
a. An identification number should be assigned to all reference substances, except for pharmacopeial
reference substances.
b. A new identification number should be assigned to each new batch.
c. This number should be marked on each vial of the reference substance.
d. The identification number should be quoted on the analytical worksheet every time the reference
substance is used.
29
e. The register for all reference substances and reference materials should be maintained and contain the
following information:
i. The identification number of the substance or material.
ii. A precise description of the substance or material.
iii.The source.
iv.The date of receipt.
v. The intended use of the substance or material (e.g., as an infrared reference substance or as an
impurity reference substance for Thin-layer Chromatography).
vi.The location of storage in the laboratory, and any special storage conditions.
vii.Expiry date or retest date.
viii.The certificate of analysis, in the case of secondary reference substances prepared and supplied by
the manufacturer.
 A person should be nominated to be responsible for reference substances and reference materials.
30
 If a national pharmaceutical quality control laboratory is required to establish reference substances for use
by other institutions, a separate reference substances unit should be established; In addition, a file should
be kept in which all information on the properties of each reference substance is entered.
 Retesting (for monitoring):
a. All reference substances prepared in the laboratory or supplied externally should be retested at regular
intervals to ensure that deterioration has not occurred.
b. The results of these tests should be recorded and signed by the responsible analyst.
c. In the case that the result of retesting of a reference substance is noncompliant, a retrospective check
of tests performed using this reference substance since its previous examination should be carried out,
for evaluation of outcomes of retrospective checks and consideration of possible corrective actions.
d. Pharmacopeial reference substances are regularly retested and the validity of these reference
substances is available from the issuing pharmacopoeia by various means (e.g., their website or
catalogue) so retesting by the laboratory is not necessary.
31
3- Calibration, Verification of Performance and Qualification of Equipment, Instruments and Other Devices
 Each item of equipment used should be uniquely identified.
 All equipment, instruments and other devices (e.g., incubators and balances) requiring calibration should be
labelled to indicate the status of calibration and the date when recalibration is due.
 Laboratory equipment should undergo design qualification, installation qualification, operation qualification
and performance qualification.
 Measuring equipment should be regularly calibrated and the performance of equipment should be verified at
appropriate intervals according to a plan established by the laboratory.
 Only authorized personnel should operate equipment, instruments and devices.
 Up-to-date SOPs and relevant equipment manuals provided by the manufacturer should be readily available.
 Maintenance procedures should be established (e.g., regular servicing should be performed by a team of
maintenance specialists, followed by verification of performance).
32
 Records of equipment should be kept, and include the following:
a. The identity of the device.
b. The manufacturer’s name and the equipment model, serial number or other unique identification.
c. The calibration required.
d. The dates, results and copies of certificates of all calibrations.
e. The maintenance carried out to date and the maintenance plan.
f. A history of any damage, malfunction or modification.
 The Laboratory should implement procedures for the safe handling, transport and storage of measuring
equipment and its requalification on reinstallation.
 Equipment, instruments and other devices subjected to overloading or mishandling, giving suspect results,
shown to be defective or outside specified limits, should be taken out of service and clearly labelled or
marked. They should not be used until they have been repaired and requalified.
33
4- Traceability
 The result of an analysis should be traceable; When appropriate, to a primary reference substance.
 All calibrations or qualification of instruments should be traceable; When appropriate, to certified reference
materials and to SI units (International System of Units).
34
Working Procedures
Part Three
35
1- Incoming Samples
 Samples received by a laboratory may be for compliance testing or for investigative testing:
a. Samples for compliance testing include:
i. Routine samples for control.
ii. Samples suspected of not complying with the specifications.
iii.Samples submitted in connection with a marketing authorization process.
b. Samples for investigative testing may be submitted by various sources including customs, police and
medicines inspectors. These samples comprise suspicious, illegal or counterfeit substances or products.
 Usually, the primary objective of investigative testing is to identify the substance or the ingredient in the
product and to estimate the purity or content.
 Close collaboration with the providers of the samples is important (e.g., it is important that the sample is
large enough to enable, if required, a number of replicate tests to be carried out and for part of the sample to
be retained).
36
 The result obtained should be reported with an indication of the uncertainty of measurement if required.
 It is common for a sample to be taken and divided into three approximately equal portions for submission
to the laboratory:
a. One for immediate testing.
b. The second for confirmation of testing if required.
c. The third for retention in case of dispute.
 Samples should be representative of the batches of material from which they are taken; Sampling should
be carried out so as to avoid contamination and other adverse effects on the quality of the test result.
37
 Test request: A standard test request form should be filled out and should accompany each sample
submitted to the laboratory, the form should provide the following information:
a. The name of the institution or inspector that supplied the sample.
b. The source of the material.
c. A full description of the medicine, including its composition, INN (international nonproprietary name)
and brand name.
d. Dosage form and concentration or strength; The manufacturer and batch number.
e. The size of the sample.
f. The reason for requesting the analysis.
g. The date on which the sample was collected.
h. The size of the preparation from which it was taken.
i. The expiry date (for pharmaceutical products) or retest date (for APIs and pharmaceutical excipients).
j. The specification to be used for testing.
k. The required storage conditions.
38
 The laboratory should review the test request to ensure that:
a. The requirements are adequately defined and the laboratory has the capability and resources to meet
them.
b. The appropriate tests and methods are selected and are capable of meeting requirements.
 Any issue should be resolved with the originator of the request for analysis before testing starts and a
record of it should be kept.
 Registration and labelling:
a. All newly delivered samples and accompanying documents (e.g., the test request) should be assigned a
registration number.
b. A label bearing the registration number should be affixed to each container of the sample. Care should
be taken to avoid obscuring any other markings or inscriptions.
c. A register should be kept in which the following information is recorded:
i. The registration number of the sample.
ii. The date of receipt.
iii.The specific unit to which the sample was forwarded. 39
 Visual inspection of the submitted sample:
a. The sample received should be visually inspected by laboratory staff to ensure that the labelling
conforms with the information contained in the test request.
b. The findings should be recorded.
c. If discrepancies are found, or if the sample is obviously damaged, this fact should be recorded without
delay on the test request form.
d. Any queries should be immediately referred back to the provider of the sample.
 Forwarding for testing:
a. The examination of a sample should not be started before the relevant test request has been received.
However, A request for analysis may be accepted verbally only in emergencies. All details should
immediately be placed on record following the receipt of written confirmation.
b. Unless a computerized system is used, copies or duplicates of all documentation should accompany
each numbered sample when sent to the specific unit.
40
2- Analytical Worksheet
 The analytical worksheet is an internal document to be used by the analyst for recording information about
the sample, the test procedure, calculations and the results of testing.
 A separate analytical worksheet should usually be used for each numbered sample or group of samples;
Analytical worksheets from different units relating to the same sample should be assembled together.
 (Its Purpose) The analytical worksheet contains documentary evidence to:
a. Confirm that the sample being examined is in accordance with the requirements.
b. Support an OOS result.
 (Its Content) The analytical worksheet should provide the following information:
a. The registration number of the sample.
b. The date of the test request.
c. The date on which the analysis was started and completed.
d. The name and signature of the analyst.
41
e. A description of the sample received.
f. Reference to the specifications including the limits.
g. The identification number of any reference substance used.
h. The identification of reagents and solvents employed.
i. The results obtained, and the interpretation of the results and the final conclusions (whether the
sample was found to comply with the specifications or not), approved and signed by the supervisor.
j. Any further comments (e.g., internal information, deviation from the prescribed procedure, whether
portions of the sample were forwarded to other units for special tests and the date on which the
results were received).
 When a mistake is made in an analytical worksheet or when data or text need to be amended, the old
information should be corrected by jotting down a single line through it (it should not be erased or made
illegible) and the new information added alongside. All such alterations should be signed by the person
making the correction and the date of the change inserted.
42
 Selection of the specifications to be used:
a. The specification necessary to assess the sample may be that given in the test request or master
production instructions. If no precise instruction is given, the specification in the officially recognized
national pharmacopoeia may be used; failing this, the manufacturer’s officially approved or other
nationally recognized specification.
b. If no suitable method is available:
i. The specification contained in the marketing authorization or product license may be requested
from the marketing authorization holder and verified by the laboratory.
ii. The requirements may be set by the laboratory itself on the basis of published information and any
procedure employed is to be validated by the testing laboratory.
c. For official specifications, the current version of the relevant pharmacopoeia should be available.
 The analytical worksheet should be kept safely together with any attachments, including calculations and
recordings of instrumental analyses (proper filing).
43
3- Validation of Analytical Procedures
 All analytical procedures employed for testing should be suitable for the intended use (validated).
 Validation serves to establish acceptance criteria for system suitability tests which are subsequently employed
for the verification of the analytical procedure before analysis.
 Pharmacopeial methods are considered to be validated for the intended use as prescribed in the monographs.
 However, the laboratory should also confirm that, for example:
a. For a particular finished pharmaceutical product (FPP) examined for the first time, no interference arises
from the excipients present.
b. For an API, impurities coming from a new route of synthesis are adequately recognized.
 Any major change to the analytical procedure, or in the composition of the product tested, or in the synthesis of
the API, will require revalidation of the analytical procedure.
44
4- Testing
 The sample should be tested in accordance with the work plan of the laboratory after completion of the
preparatory procedures.
 Test procedures should be described in detail and should provide sufficient information to allow properly
trained analysts to perform the analysis in a reliable manner.
 Any deviation from the test procedure should be approved and documented.
 Specific tests may need to be carried out by another unit or by a specialized external laboratory, the results of
such tests should be identified as such.
45
5- Evaluation of Test Results
 Test results should be reviewed, this evaluation should take into consideration the results of all the test data.
 Whenever doubtful (atypical or OOS) results are obtained they should be investigated, during which, the
supervisor alongside the analyst or technician should review the different procedures applied during the
testing process before retesting is permitted; the investigation follows these steps:
a. Confirm with the analyst or technician that the appropriate procedures were applied and followed
correctly.
b. Examine the raw data to identify possible discrepancies.
c. Check all calculations.
d. Check that the equipment used was qualified and calibrated and that system suitability tests were
performed and were acceptable.
e. Ensure that the appropriate reagents, solvents and reference substances were used.
f. Confirm that the correct glassware was used.
g. Ensure that original sample preparations are not discarded until the investigation is complete.
46
 The identification of an error which caused an atypical result will invalidate the result and a retest of the
sample will be necessary.
 Sometimes the outcome of the investigation is inconclusive, meaning there is no obvious cause can be
identified, in which case a confirmatory determination is to be performed by another analyst who should
be at least as experienced and competent in the analytical procedure as the original analyst; A similar value
would indicate an OOS result.
 All investigations and their conclusions should be recorded. In the event of an error, any corrective action
taken and any preventive measure introduced should also be recorded.
 The reporting is done via an analytical test report issued by the laboratory, based on the analytical
worksheet mentioned before.
47
 The Analytical test report and its content:
a. The name and address of the laboratory testing the sample.
b. The laboratory registration number of the sample.
c. The name of the originator of the request for analysis.
d. The date on which the sample was received.
e. The date on which the test was completed.
f. The name and batch number of the sample.
g. The expiry date or retest date.
h. A reference to the specifications used for testing the sample including the limits.
i. The results of all the tests performed.
j. A conclusion as to whether or not the sample was found to be within the limits of the specifications
used.
k. The signature of the head of the laboratory or the authorized deputy.
l. A statement indicating that the analytical test report, or any portion thereof, cannot be reproduced
without the authorization of the laboratory. 48
6- Retained Samples
 Samples should be retained as required by the legislation or by the originator of the request for analysis.
There should be a sufficient amount of retained sample to allow at least two re-analyses. The retained sample
should be kept in its final pack.
49
Safety
Part Four
50
- General Rules
 Specific safety instructions indicating known risks should be made available to each staff member in the form
of written material, poster displays, audiovisual material and occasional seminars.
 Rules for safe working in accordance with national regulations normally include the following requirements:
a. Safety data sheets (SDS) should be available to staff before testing is carried out.
b. Smoking, eating and drinking in the laboratory, outside designated areas for such activities, should be
prohibited.
c. Staff should be familiar with the use of fire-fighting equipment, including fire extinguishers, fire blankets
and gas masks.
d. Staff should wear laboratory coats and other protective clothing, including eye protection, gloves and
masks.
e. Special care should be taken in handling highly potent, infectious or volatile substances.
f. All containers of chemicals should be fully labelled and include prominent warnings (e.g., Poison,
Flammable, Radioactive). 51
g. Adequate insulation and spark-proofing should be provided for electrical wiring and equipment (e.g.,
refrigerators, Incubators, LAFs and other devices).
h. Staff should be aware of the need to avoid working alone in the laboratory.
i. First-aid materials should be provided and staff instructed in first-aid techniques, emergency care and
the use of antidotes.
 Safety showers should be installed.
 Rubber suction bulbs should be used on manual pipettes and siphons.
 Staff should be instructed in the safe handling of glassware, corrosive reagents and solvents and in the use
of safety containers to avoid spillage from normal containers.
 Staff should be aware of methods for the safe disposal of unwanted corrosive or dangerous products by
neutralization or deactivation and of the need for safe and complete disposal of Mercury and its salts.
 Poisonous or hazardous products should be singled out and labelled appropriately, but it should not be
taken for granted that all other chemicals and biologicals are safe.
 Handling carcinogens and mutagens should be limited or totally excluded if required by national
regulations. 52
Remember…
Safety First!
And thank you for listening
Ya Dr. Ahmed
53
References, Definitions, Elaborations
Annexes
54
 Definitions
 System of Change Control: is a systematic approach to managing all changes made to a product or system. The
purpose is to ensure that no unnecessary changes are made, that all changes are documented, that services
are not unnecessarily disrupted and that resources are used efficiently.
 Proficiency Testing: Proficiency testing determines the performance of individual laboratories for specific tests
or measurements and is used to monitor laboratories’ continuing performance.
 Design Qualification (DQ): Documented collection of activities that define the functional and operational
specifications of the instrument and criteria for selection of the vendor, based on the intended purpose of the
instrument.
 Installation Qualification (IQ): The performance of tests to ensure that the analytical equipment used in a
laboratory is correctly installed and operates in accordance with established specifications.
 Operational Qualification (OQ): Documented verification that the analytical equipment performs as intended
over all anticipated operating ranges.
 Performance Qualification (PQ): Documented verification that the analytical equipment operates consistently
and gives reproducibility within the defined specifications and parameters for prolonged periods.
 Validation of an Analytical Procedure: The documented process by which an analytical procedure (or method)
is demonstrated to be suitable for its intended use. 55
 Definitions
 System Suitability Test (SST): A test which is performed to ensure that the analytical procedure fulfils the
acceptance criteria which had been established during the validation of the procedure. This test is performed
before starting the analytical procedure and is to be repeated regularly, as appropriate, throughout the
analytical run to ensure that the system’s performance is acceptable at the time of the test.
 Marketing Authorization: A legal document issued by the competent medicines regulatory authority that
authorizes the marketing or free distribution of a pharmaceutical product in the respective country after
evaluation for safety, efficacy and quality.
 Safety Data Sheet (SDS): is a document produced in alignment with the UN’s Globally Harmonized System of
Classification and Labelling of Chemicals (GHS), its purpose is to ensure that all workers who handle chemicals
have the hazard information they need to safely use, handle and store them.
 Analytical Worksheet: A printed form, an analytical workbook or electronic means (e-records) for recording
information about the sample, as well as reagents and solvents used, test procedure applied, calculations
made, results and any other relevant information or comments.
56
 Definitions
 Validation of an Analytical Procedure: The documented process by which an analytical procedure (or method)
is demonstrated to be suitable for its intended use.
 Verification of an Analytical Procedure: Process by which a pharmacopeial method or validated analytical
procedure is demonstrated to be suitable for the analysis to be performed.
 Verification of Performance: Test procedure regularly applied to a system (e.g. liquid chromatographic system)
to demonstrate consistency of response.
57
 What is a measurement?
• A measurement tells us about a property of something. It might tell us how heavy an object is, or
how hot, or how long it is. A measurement gives a number to that property.
• Measurements are always made using an instrument of some kind (e.g., rulers, stopwatches,
weighing scales and thermometers).
• The result of a measurement is normally in two parts: 1) a number and 2) a unit of measurement
(e.g., How long is something? 2 meters).
 What is NOT a measurement?
• There are some processes that might seem to be measurements, but are not. For example,
comparing two pieces of string to see which is longer is not a measurement. Counting is not a
measurement. Often, a test is not a measurement, tests normally lead to a yes/no answer or a
pass/fail result. However, measurements may be part of the process leading up to a test result.
 It is important not to confuse the terms ‘error’ and ‘uncertainty’.
• Error is the difference between the measured value and the true value of the thing being measured.
• Uncertainty is a quantification of the doubt about the measurement result.
E
l
a
b
o
r
a
t
i
o
n
s
58
 What is uncertainty of measurement?
• Uncertainty of measurement is the doubt that exists about the result of any measurement. Meaning:
You might think that well-made rulers, clocks and thermometers should be trustworthy, and give the
right answers. But for every measurement, even the most careful, there is always a margin of doubt.
This might be expressed as ‘give or take’ (e.g., a ruler might be two meters long ‘give or take’ a
centimeter).
 How to express uncertainty of measurement?
• Since there is always a margin of doubt about any measurement, we need to ask (1) How big is the
margin? and (2) How bad is the doubt?.
• Thus, two numbers are really needed in order to quantify an uncertainty. One is the width of the
margin, or an interval. The other is a confidence level, it states how sure we are that the ‘true value’ is
within that margin.
• For example:
 We might say that the length of a certain ruler measures 20 centimeters plus or minus 1
centimeter, at the 95 percent confidence level.
 This result will be written as such: 20cm ± 1cm, at a level of confidence of 95%.
 The statement says that we are 95 percent sure that the stick is between 19 centimeters and 21
centimeters long.
E
l
a
b
o
r
a
t
i
o
n
s
59
Reference
© World Health Organization WHO
Technical Report Series, No. 957, 2010
60

Good Laboratory Practice (GLP) - General [Manual]

  • 1.
    Good Practices ForPharmaceutical Quality Control Laboratories F o u a d A s h r a f – E D A , M i c r o b i o l o g y L a b o r a t o r y E l - A g o u z a 1
  • 2.
    General Considerations • Theseguidelines are applicable to any pharmaceutical quality control laboratory, be it national, commercial or nongovernmental. • However, they do not include guidance for those laboratories involved in the testing of biological products (e.g., vaccines and blood products), separate guidance for such laboratories is available. 2
  • 3.
    • National pharmaceuticalquality control laboratories usually encompass essentially two types of activity: a. Compliance testing of APIs, pharmaceutical excipients and pharmaceutical products employing official pharmacopeial methods. b. Investigative testing of suspicious, illegal, counterfeit substances or products, submitted for examination by medicine inspectors, customs or police. • Note: To ensure patient safety, the role of the national pharmaceutical quality control laboratory should be defined in the general pharmaceutical legislation of the country in such a way that the results provided by it can, if necessary, lead to enforcement of the law and legal action. 3
  • 4.
    Good Laboratory Practice I.Management and Infrastructure II. Materials, Equipment, Instruments and Other Devices III. Working Procedures IV. Safety 4
  • 5.
  • 6.
    • The laboratoryshould be legally authorized to function and can be held legally responsible. • The laboratory should be organized and operate so as to meet the requirements laid down in these guidelines. • The laboratory should: a. Have managerial and technical personnel with the authority and resources needed to carry out their duties, and to identify the occurrence of departures from the quality management system. b. Have arrangements to ensure that its management and personnel are not subject to commercial, political, financial and other pressures or conflicts of interest that may adversely affect the quality of their work. c. Designate a member of staff as Quality Manager, who, irrespective of other duties they may have, will ensure compliance with the quality management system. The nominated quality manager should have direct access to the highest level of management at which decisions are taken on laboratory policies or resources. 1- Organization & Management 6
  • 7.
    d. Have apolicy in place to ensure confidentiality of information, transfer of results and reports, data in archives. e. Define its place in any parent organization and the relationships between management, technical operations and support services. f. Ensure the precise allocation of responsibilities. g. Provide adequate supervision of staff, including trainees. h. Ensure adequate information flow between staff at all levels. i. Ensure the traceability of the sample from receipt, throughout the stages of testing, to the completion of the analytical test report. • The laboratory should maintain a registry with the following functions: a. Keeping records on all incoming samples and accompanying documents. b. Distributing and supervising the consignment of the samples to the specific units. • In a large laboratory, it is necessary to guarantee communication and coordination between the staff involved in the testing of the same sample in different units. 7
  • 8.
    2- Quality ManagementSystem  The laboratory management should establish, implement and maintain a quality management system appropriate to the scope of its activities, including the type and volume of testing and the calibration, validation and verification activities it undertakes.  The documentation used in this quality management system should be communicated, available to, and understood and implemented by, the appropriate personnel.  The elements of this system should be documented in a quality manual, for the organization as a whole or for the laboratory within the organization.  The quality manual should contain as a minimum: a. A quality policy statement including: i. A statement of the laboratory management’s intentions with respect to the service it will provide. ii. The laboratory management’s commitment to good professional practice and quality of testing, calibration and validation. iii. A requirement that all personnel concerned with testing and calibration activities within the laboratory familiarize themselves with the documentation concerning quality and the implementation of the policies and procedures in their work. 8
  • 9.
    b. The structureof the laboratory (organizational chart). c. References to specific procedures for each test. d. Information on the appropriate qualifications and experience that personnel are required to possess. e. Information on initial and in-service training of staff. f. A policy for internal and external audit. g. A policy for implementing and verifying corrective and preventive actions. h. A policy for dealing with complaints. i. A policy for selecting and approving analytical procedures. j. A policy for handling of out of specification (OOS) results. k. A policy for the employment of appropriate reference substances and reference materials. l. A policy to select service providers and suppliers.  The laboratory should implement and maintain authorized written SOPs, including but not limited to: a. Personnel training, clothing and hygiene. b. Internal audit. c. Dealing with complaints. d. Implementation corrective and preventive actions. 9
  • 10.
    e. The purchaseand receipt of consignments of materials (e.g., samples, media, reagents). f. Obtainment, preparation and control of reference substances and reference materials. g. The internal labelling and storage of materials. h. The qualification of equipment. i. The calibration of equipment. j. The testing of samples with descriptions of the methods and equipment used. k. Atypical and OOS results. l. Validation of analytical procedures. m.Cleaning of laboratory facilities, including bench tops, equipment, work stations, clean rooms and glassware. n. Monitoring of environmental conditions (e.g., temperature and humidity); monitoring of storage conditions. o. Disposal of reagents and solvent samples. p. Safety measures. 10
  • 11.
     The activitiesof the laboratory should be systematically and periodically audited, internally and by external audits, to verify compliance with the requirements of the quality management system and to apply corrective and preventive actions, if necessary.  Management review of quality issues should be undertaken annually, and it includes: a. Reports on internal and external audits. b. The outcome of investigations carried out as a result of complaints received, doubtful, atypical or aberrant results reported. c. Corrective actions applied and preventive actions introduced as a result of these investigations. 11
  • 12.
    3- Control ofDocumentation  Documentation is an essential part of the quality management system; The laboratory should establish and maintain procedures to control and review all documents (both internally generated and from external sources).  The procedures should ensure that: a. Each document, technical or quality, has a unique identifier, version number and date of implementation. b. Appropriate, authorized SOPs are available at the relevant locations (e.g., near instruments). c. Documents are kept up to date and reviewed as required; any invalid document is removed and replaced with the authorized, revised version. d. A revised document includes references to the previous document. e. Old, invalid documents are retained in the archives to ensure traceability of the evolution of the procedures; copies are destroyed. f. All relevant staff are trained for the new and revised SOPs. g. Quality documentation, including records, is retained for a minimum of five years. 12
  • 13.
     A systemof change control should be in place to inform staff of new and revised procedures. The system should ensure that: a. Revised documents are 1) prepared by a person who performs the same function 2) reviewed and approved at the same level as the original document. b. Staff acknowledge by a signature that they are aware of applicable changes and their date of implementation. 13
  • 14.
    4- Records  Thelaboratory should establish and maintain procedures for the identification, collection, indexing, retrieval, storage, maintenance and disposal of and access to all quality, technical and scientific records.  All original observations, including calculations and derived data, calibration, validation and verification records and final results, should be retained on record for an appropriate period of time.  The records should include the data recorded in the analytical worksheet by the technician or analyst on consecutively numbered pages.  The records should include the identity of the personnel involved in the testing of the samples.  All records (including analytical test reports, certificates of analysis) should be legible, readily retrievable, stored and retained within facilities that provide a suitable environment that will prevent modification, damage, deterioration or loss. And as to ensure their security and confidentiality. 14
  • 15.
    5- Data-processing Equipment For computers, automated tests or calibration equipment, and the collection, processing, recording, reporting, storage or retrieval of the data they produce, the laboratory should ensure that: a. Computer software developed by the user is documented in sufficient detail and appropriately validated or verified as being suitable for use. b. Procedures are implemented for protecting the integrity and confidentiality of data. c. Electronic data should be backed up at appropriate regular intervals according to a documented procedure. Backed-up data should be retrievable and stored in such a manner as to prevent data loss. 15
  • 16.
    6- Personnel  Thelaboratory should have sufficient personnel with the necessary education, training, technical knowledge and experience for their assigned functions.  The technical management should ensure the competence of all personnel operating specific equipment, instruments or other devices, who are performing tests or calibrations, validations or verifications. Their duties also involve the evaluation of results as well as signing analytical test reports and certificates of analysis.  Staff undergoing training should be appropriately supervised and should be assessed on completion of the training.  The laboratory personnel should be permanently employed or under contract.  The laboratory should maintain: a. Current job descriptions for all personnel involved in tests, calibrations, validations and verifications. b. Records of all technical personnel, describing their qualifications, training and experience. 16
  • 17.
     The laboratoryshould have the following managerial and technical personnel: a. A Head of Laboratory (Supervisor) who is responsible for the content of certificates of analysis and analytical testing reports, and is also responsible for ensuring that: i. All key members of the laboratory staff have the necessary competence for the required functions and responsibilities. ii. The adequacy of existing staffing, management and training procedures is reviewed periodically. iii.The technical management is adequately supervised. b. A Quality Manager (see part one, point 3-c). c. The Technical Management who ensure that: i. Procedures for performing calibration, verification and requalification of instruments, monitoring of environmental and storage conditions are in place and are conducted as required. ii. Training programs to update and extend the skills of personnel are arranged. iii.The safekeeping of any materials subject to poison regulation or to the controls applied to narcotic and psychotropic substances kept in the workplace is under the supervision of an authorized person. 17
  • 18.
    iv. National pharmaceuticalquality control laboratories regularly participate in suitable proficiency testing schemes and collaborative trials to assess analytical procedures or reference substances. d. Analysts, who should normally be graduates in Pharmacy, Analytical Chemistry, Microbiology or other relevant subjects, with the requisite knowledge, skills and ability to adequately perform the tasks assigned to them by management and to supervise technical staff. e. Technical Staff, who should hold diplomas in their subjects awarded by technical or vocational schools. 18
  • 19.
    7- Premises  Thelaboratory facilities are to be of a suitable size, designed to suit the functions and operations to be conducted in them.  Changing areas and toilets should be easily accessible and appropriate for the number of users.  The laboratory facilities should have adequate safety equipment located appropriately.  The laboratory should be equipped with adequate instruments and equipment, including work benches and stations.  The environmental conditions, including lighting, energy sources, temperature, humidity and air pressure, are to be appropriate to the functions and operations to be performed; these conditions are to be documented.  There should be a separate and dedicated unit or equipment (e.g., laminar flow workbench) to handle, weigh and manipulate highly toxic substances; procedures should be in place to avoid exposure and contamination. 19
  • 20.
     Archive facilitiesshould be provided to ensure the secure storage and retrieval of all documents; Access to the archives should be restricted to designated personnel.  Tools/material should be in place for the safe removal of types of waste, including toxic waste (chemical and biological), reagents, samples, solvents and air filters.  Microbiological testing, if performed, should be contained in an appropriately designed and constructed laboratory unit. (For further guidance see the document: WHO guideline on good practices for pharmaceutical microbiology laboratories [reference QAS/09.297]).  If in vivo biological testing (e.g., rabbit pyrogen test) is included in the scope of the laboratory activities, then the animal houses should be isolated from the other laboratory areas with a separate entrance and air-conditioning system. 20
  • 21.
     Laboratory storagefacilities should: a. Be well organized. b. Be separate for the storage of samples, laboratory accessories, reference substances and reference materials. c. Have separate rooms or areas for storing flammable substances, fuming and concentrated acids and bases, volatile amines and other reagents (e.g., hydrochloric acid, nitric acid, ammonia and bromine) and Self-igniting materials (e.g., metallic sodium and potassium). d. Be equipped to store material under refrigeration (2-8°C) and frozen (-20°C). e. Have a dedicated storage area for gases, isolated from the main building if possible. 21
  • 22.
    8- Equipment, Instrumentsand Other Devices  The laboratory should have the required test equipment, instruments and other devices for the correct performance of the tests, calibrations and validations.  Equipment, instruments and other devices should be designed, constructed, adapted, located, calibrated, qualified, verified and maintained as required by the operations to be carried out in the local environment.  It should be purchased from an agent capable of providing full technical support and maintenance when necessary. 22
  • 23.
    9- Contracts  Purchasingservices and supplies: a. The laboratory should have a procedure for the selection and purchasing of services and supplies it uses that affect the quality of testing. b. The laboratory should evaluate suppliers of critical consumables (e.g., Petri Dishes), maintain records of these evaluations, list approved suppliers which have been demonstrated to be of suitable quality with respect to the requirements of the laboratory.  Subcontracting of testing: a. When the laboratory subcontracts work, it is to be done with organizations approved for the type of activity required. b. When a laboratory performs testing for a customer and subcontracts part of the testing, it should advise the customer of the arrangement in writing and gain their approval. 23
  • 24.
    c. There shouldbe a contract that permit the laboratory to audit the facilities and competencies of the contracted organization and ensure the access of the laboratory to their records and retained samples. d. The contracted organization should not pass to a third party any work entrusted to it under contract without the laboratory’s prior evaluation and approval of the arrangements. e. The laboratory should maintain a register of all subcontractors that it uses, and a record of the assessment of their competence. f. The laboratory takes the responsibility for all results reported, including those furnished by the subcontracting organization. 24
  • 25.
    Materials, Equipment, Instruments andOther Devices Part Two 25
  • 26.
    1- Reagents  Allreagents and chemicals used in tests and assays, should be of appropriate quality.  Reagents should be purchased from reputable, approved suppliers and accompanied by the certificate of analysis.  Regarding preparation of reagent solutions in the laboratory: a. Responsibility for this task should be clearly specified in the job description of the person assigned to carry it out. b. Pharmacopeial prescribed procedures should be used. c. Records of the preparations should be kept.  The labels of all reagents should clearly specify: a. Content. b. Manufacturer. c. Date received and date of opening of the container. d. Concentration, if applicable. e. Storage conditions required. f. Expiry date or retest date. 26
  • 27.
     The labelsof reagents prepared in the laboratory should clearly specify: a. Name. b. Date of preparation and initials of technician or analyst. c. Expiry date or retest date. d. Concentration, if applicable.  Regarding the transportation and subdivision of reagents: a. They should be transported in the original containers. b. When subdivision is necessary, clean and appropriately labelled containers should be used.  Visual Inspection: a. All reagent containers should be visually inspected to ensure that the seals are intact. b. Reagents that appear to have been tampered with should be rejected; however, this may exceptionally be waived if the identity and purity of the reagent concerned can be confirmed by testing. 27
  • 28.
     Water: a. Watershould be considered as a reagent. b. Precautions should be taken to avoid contamination during its supply, storage and distribution. c. The quality of the water should be verified regularly to ensure that the various grades of water meet the appropriate specifications.  Storage: a. Stocks of reagents should be maintained under the appropriate storage conditions (e.g., ambient temperature, under refrigeration or frozen). b. The store should contain a supply of clean bottles, vials, spoons and funnels for dispensing reagents from larger to smaller containers. c. Special equipment may be needed for the transfer of larger volumes of corrosive liquids. d. The person in charge of the store is responsible for the inventory and for noting the expiry date of chemicals and reagents. e. Training may be needed in handling chemicals safely and with the necessary care. 28
  • 29.
    2- Reference Substancesand Reference Materials  Reference substances (primary and secondary) are used for the testing of a sample; Pharmacopeial reference substances should be employed when available; When a pharmacopoeia reference substance has not been established then the manufacturer should use its own reference substance.  Reference materials may be necessary for the calibration and/or qualification of equipment, instruments or other devices.  Registration and labelling: a. An identification number should be assigned to all reference substances, except for pharmacopeial reference substances. b. A new identification number should be assigned to each new batch. c. This number should be marked on each vial of the reference substance. d. The identification number should be quoted on the analytical worksheet every time the reference substance is used. 29
  • 30.
    e. The registerfor all reference substances and reference materials should be maintained and contain the following information: i. The identification number of the substance or material. ii. A precise description of the substance or material. iii.The source. iv.The date of receipt. v. The intended use of the substance or material (e.g., as an infrared reference substance or as an impurity reference substance for Thin-layer Chromatography). vi.The location of storage in the laboratory, and any special storage conditions. vii.Expiry date or retest date. viii.The certificate of analysis, in the case of secondary reference substances prepared and supplied by the manufacturer.  A person should be nominated to be responsible for reference substances and reference materials. 30
  • 31.
     If anational pharmaceutical quality control laboratory is required to establish reference substances for use by other institutions, a separate reference substances unit should be established; In addition, a file should be kept in which all information on the properties of each reference substance is entered.  Retesting (for monitoring): a. All reference substances prepared in the laboratory or supplied externally should be retested at regular intervals to ensure that deterioration has not occurred. b. The results of these tests should be recorded and signed by the responsible analyst. c. In the case that the result of retesting of a reference substance is noncompliant, a retrospective check of tests performed using this reference substance since its previous examination should be carried out, for evaluation of outcomes of retrospective checks and consideration of possible corrective actions. d. Pharmacopeial reference substances are regularly retested and the validity of these reference substances is available from the issuing pharmacopoeia by various means (e.g., their website or catalogue) so retesting by the laboratory is not necessary. 31
  • 32.
    3- Calibration, Verificationof Performance and Qualification of Equipment, Instruments and Other Devices  Each item of equipment used should be uniquely identified.  All equipment, instruments and other devices (e.g., incubators and balances) requiring calibration should be labelled to indicate the status of calibration and the date when recalibration is due.  Laboratory equipment should undergo design qualification, installation qualification, operation qualification and performance qualification.  Measuring equipment should be regularly calibrated and the performance of equipment should be verified at appropriate intervals according to a plan established by the laboratory.  Only authorized personnel should operate equipment, instruments and devices.  Up-to-date SOPs and relevant equipment manuals provided by the manufacturer should be readily available.  Maintenance procedures should be established (e.g., regular servicing should be performed by a team of maintenance specialists, followed by verification of performance). 32
  • 33.
     Records ofequipment should be kept, and include the following: a. The identity of the device. b. The manufacturer’s name and the equipment model, serial number or other unique identification. c. The calibration required. d. The dates, results and copies of certificates of all calibrations. e. The maintenance carried out to date and the maintenance plan. f. A history of any damage, malfunction or modification.  The Laboratory should implement procedures for the safe handling, transport and storage of measuring equipment and its requalification on reinstallation.  Equipment, instruments and other devices subjected to overloading or mishandling, giving suspect results, shown to be defective or outside specified limits, should be taken out of service and clearly labelled or marked. They should not be used until they have been repaired and requalified. 33
  • 34.
    4- Traceability  Theresult of an analysis should be traceable; When appropriate, to a primary reference substance.  All calibrations or qualification of instruments should be traceable; When appropriate, to certified reference materials and to SI units (International System of Units). 34
  • 35.
  • 36.
    1- Incoming Samples Samples received by a laboratory may be for compliance testing or for investigative testing: a. Samples for compliance testing include: i. Routine samples for control. ii. Samples suspected of not complying with the specifications. iii.Samples submitted in connection with a marketing authorization process. b. Samples for investigative testing may be submitted by various sources including customs, police and medicines inspectors. These samples comprise suspicious, illegal or counterfeit substances or products.  Usually, the primary objective of investigative testing is to identify the substance or the ingredient in the product and to estimate the purity or content.  Close collaboration with the providers of the samples is important (e.g., it is important that the sample is large enough to enable, if required, a number of replicate tests to be carried out and for part of the sample to be retained). 36
  • 37.
     The resultobtained should be reported with an indication of the uncertainty of measurement if required.  It is common for a sample to be taken and divided into three approximately equal portions for submission to the laboratory: a. One for immediate testing. b. The second for confirmation of testing if required. c. The third for retention in case of dispute.  Samples should be representative of the batches of material from which they are taken; Sampling should be carried out so as to avoid contamination and other adverse effects on the quality of the test result. 37
  • 38.
     Test request:A standard test request form should be filled out and should accompany each sample submitted to the laboratory, the form should provide the following information: a. The name of the institution or inspector that supplied the sample. b. The source of the material. c. A full description of the medicine, including its composition, INN (international nonproprietary name) and brand name. d. Dosage form and concentration or strength; The manufacturer and batch number. e. The size of the sample. f. The reason for requesting the analysis. g. The date on which the sample was collected. h. The size of the preparation from which it was taken. i. The expiry date (for pharmaceutical products) or retest date (for APIs and pharmaceutical excipients). j. The specification to be used for testing. k. The required storage conditions. 38
  • 39.
     The laboratoryshould review the test request to ensure that: a. The requirements are adequately defined and the laboratory has the capability and resources to meet them. b. The appropriate tests and methods are selected and are capable of meeting requirements.  Any issue should be resolved with the originator of the request for analysis before testing starts and a record of it should be kept.  Registration and labelling: a. All newly delivered samples and accompanying documents (e.g., the test request) should be assigned a registration number. b. A label bearing the registration number should be affixed to each container of the sample. Care should be taken to avoid obscuring any other markings or inscriptions. c. A register should be kept in which the following information is recorded: i. The registration number of the sample. ii. The date of receipt. iii.The specific unit to which the sample was forwarded. 39
  • 40.
     Visual inspectionof the submitted sample: a. The sample received should be visually inspected by laboratory staff to ensure that the labelling conforms with the information contained in the test request. b. The findings should be recorded. c. If discrepancies are found, or if the sample is obviously damaged, this fact should be recorded without delay on the test request form. d. Any queries should be immediately referred back to the provider of the sample.  Forwarding for testing: a. The examination of a sample should not be started before the relevant test request has been received. However, A request for analysis may be accepted verbally only in emergencies. All details should immediately be placed on record following the receipt of written confirmation. b. Unless a computerized system is used, copies or duplicates of all documentation should accompany each numbered sample when sent to the specific unit. 40
  • 41.
    2- Analytical Worksheet The analytical worksheet is an internal document to be used by the analyst for recording information about the sample, the test procedure, calculations and the results of testing.  A separate analytical worksheet should usually be used for each numbered sample or group of samples; Analytical worksheets from different units relating to the same sample should be assembled together.  (Its Purpose) The analytical worksheet contains documentary evidence to: a. Confirm that the sample being examined is in accordance with the requirements. b. Support an OOS result.  (Its Content) The analytical worksheet should provide the following information: a. The registration number of the sample. b. The date of the test request. c. The date on which the analysis was started and completed. d. The name and signature of the analyst. 41
  • 42.
    e. A descriptionof the sample received. f. Reference to the specifications including the limits. g. The identification number of any reference substance used. h. The identification of reagents and solvents employed. i. The results obtained, and the interpretation of the results and the final conclusions (whether the sample was found to comply with the specifications or not), approved and signed by the supervisor. j. Any further comments (e.g., internal information, deviation from the prescribed procedure, whether portions of the sample were forwarded to other units for special tests and the date on which the results were received).  When a mistake is made in an analytical worksheet or when data or text need to be amended, the old information should be corrected by jotting down a single line through it (it should not be erased or made illegible) and the new information added alongside. All such alterations should be signed by the person making the correction and the date of the change inserted. 42
  • 43.
     Selection ofthe specifications to be used: a. The specification necessary to assess the sample may be that given in the test request or master production instructions. If no precise instruction is given, the specification in the officially recognized national pharmacopoeia may be used; failing this, the manufacturer’s officially approved or other nationally recognized specification. b. If no suitable method is available: i. The specification contained in the marketing authorization or product license may be requested from the marketing authorization holder and verified by the laboratory. ii. The requirements may be set by the laboratory itself on the basis of published information and any procedure employed is to be validated by the testing laboratory. c. For official specifications, the current version of the relevant pharmacopoeia should be available.  The analytical worksheet should be kept safely together with any attachments, including calculations and recordings of instrumental analyses (proper filing). 43
  • 44.
    3- Validation ofAnalytical Procedures  All analytical procedures employed for testing should be suitable for the intended use (validated).  Validation serves to establish acceptance criteria for system suitability tests which are subsequently employed for the verification of the analytical procedure before analysis.  Pharmacopeial methods are considered to be validated for the intended use as prescribed in the monographs.  However, the laboratory should also confirm that, for example: a. For a particular finished pharmaceutical product (FPP) examined for the first time, no interference arises from the excipients present. b. For an API, impurities coming from a new route of synthesis are adequately recognized.  Any major change to the analytical procedure, or in the composition of the product tested, or in the synthesis of the API, will require revalidation of the analytical procedure. 44
  • 45.
    4- Testing  Thesample should be tested in accordance with the work plan of the laboratory after completion of the preparatory procedures.  Test procedures should be described in detail and should provide sufficient information to allow properly trained analysts to perform the analysis in a reliable manner.  Any deviation from the test procedure should be approved and documented.  Specific tests may need to be carried out by another unit or by a specialized external laboratory, the results of such tests should be identified as such. 45
  • 46.
    5- Evaluation ofTest Results  Test results should be reviewed, this evaluation should take into consideration the results of all the test data.  Whenever doubtful (atypical or OOS) results are obtained they should be investigated, during which, the supervisor alongside the analyst or technician should review the different procedures applied during the testing process before retesting is permitted; the investigation follows these steps: a. Confirm with the analyst or technician that the appropriate procedures were applied and followed correctly. b. Examine the raw data to identify possible discrepancies. c. Check all calculations. d. Check that the equipment used was qualified and calibrated and that system suitability tests were performed and were acceptable. e. Ensure that the appropriate reagents, solvents and reference substances were used. f. Confirm that the correct glassware was used. g. Ensure that original sample preparations are not discarded until the investigation is complete. 46
  • 47.
     The identificationof an error which caused an atypical result will invalidate the result and a retest of the sample will be necessary.  Sometimes the outcome of the investigation is inconclusive, meaning there is no obvious cause can be identified, in which case a confirmatory determination is to be performed by another analyst who should be at least as experienced and competent in the analytical procedure as the original analyst; A similar value would indicate an OOS result.  All investigations and their conclusions should be recorded. In the event of an error, any corrective action taken and any preventive measure introduced should also be recorded.  The reporting is done via an analytical test report issued by the laboratory, based on the analytical worksheet mentioned before. 47
  • 48.
     The Analyticaltest report and its content: a. The name and address of the laboratory testing the sample. b. The laboratory registration number of the sample. c. The name of the originator of the request for analysis. d. The date on which the sample was received. e. The date on which the test was completed. f. The name and batch number of the sample. g. The expiry date or retest date. h. A reference to the specifications used for testing the sample including the limits. i. The results of all the tests performed. j. A conclusion as to whether or not the sample was found to be within the limits of the specifications used. k. The signature of the head of the laboratory or the authorized deputy. l. A statement indicating that the analytical test report, or any portion thereof, cannot be reproduced without the authorization of the laboratory. 48
  • 49.
    6- Retained Samples Samples should be retained as required by the legislation or by the originator of the request for analysis. There should be a sufficient amount of retained sample to allow at least two re-analyses. The retained sample should be kept in its final pack. 49
  • 50.
  • 51.
    - General Rules Specific safety instructions indicating known risks should be made available to each staff member in the form of written material, poster displays, audiovisual material and occasional seminars.  Rules for safe working in accordance with national regulations normally include the following requirements: a. Safety data sheets (SDS) should be available to staff before testing is carried out. b. Smoking, eating and drinking in the laboratory, outside designated areas for such activities, should be prohibited. c. Staff should be familiar with the use of fire-fighting equipment, including fire extinguishers, fire blankets and gas masks. d. Staff should wear laboratory coats and other protective clothing, including eye protection, gloves and masks. e. Special care should be taken in handling highly potent, infectious or volatile substances. f. All containers of chemicals should be fully labelled and include prominent warnings (e.g., Poison, Flammable, Radioactive). 51
  • 52.
    g. Adequate insulationand spark-proofing should be provided for electrical wiring and equipment (e.g., refrigerators, Incubators, LAFs and other devices). h. Staff should be aware of the need to avoid working alone in the laboratory. i. First-aid materials should be provided and staff instructed in first-aid techniques, emergency care and the use of antidotes.  Safety showers should be installed.  Rubber suction bulbs should be used on manual pipettes and siphons.  Staff should be instructed in the safe handling of glassware, corrosive reagents and solvents and in the use of safety containers to avoid spillage from normal containers.  Staff should be aware of methods for the safe disposal of unwanted corrosive or dangerous products by neutralization or deactivation and of the need for safe and complete disposal of Mercury and its salts.  Poisonous or hazardous products should be singled out and labelled appropriately, but it should not be taken for granted that all other chemicals and biologicals are safe.  Handling carcinogens and mutagens should be limited or totally excluded if required by national regulations. 52
  • 53.
    Remember… Safety First! And thankyou for listening Ya Dr. Ahmed 53
  • 54.
  • 55.
     Definitions  Systemof Change Control: is a systematic approach to managing all changes made to a product or system. The purpose is to ensure that no unnecessary changes are made, that all changes are documented, that services are not unnecessarily disrupted and that resources are used efficiently.  Proficiency Testing: Proficiency testing determines the performance of individual laboratories for specific tests or measurements and is used to monitor laboratories’ continuing performance.  Design Qualification (DQ): Documented collection of activities that define the functional and operational specifications of the instrument and criteria for selection of the vendor, based on the intended purpose of the instrument.  Installation Qualification (IQ): The performance of tests to ensure that the analytical equipment used in a laboratory is correctly installed and operates in accordance with established specifications.  Operational Qualification (OQ): Documented verification that the analytical equipment performs as intended over all anticipated operating ranges.  Performance Qualification (PQ): Documented verification that the analytical equipment operates consistently and gives reproducibility within the defined specifications and parameters for prolonged periods.  Validation of an Analytical Procedure: The documented process by which an analytical procedure (or method) is demonstrated to be suitable for its intended use. 55
  • 56.
     Definitions  SystemSuitability Test (SST): A test which is performed to ensure that the analytical procedure fulfils the acceptance criteria which had been established during the validation of the procedure. This test is performed before starting the analytical procedure and is to be repeated regularly, as appropriate, throughout the analytical run to ensure that the system’s performance is acceptable at the time of the test.  Marketing Authorization: A legal document issued by the competent medicines regulatory authority that authorizes the marketing or free distribution of a pharmaceutical product in the respective country after evaluation for safety, efficacy and quality.  Safety Data Sheet (SDS): is a document produced in alignment with the UN’s Globally Harmonized System of Classification and Labelling of Chemicals (GHS), its purpose is to ensure that all workers who handle chemicals have the hazard information they need to safely use, handle and store them.  Analytical Worksheet: A printed form, an analytical workbook or electronic means (e-records) for recording information about the sample, as well as reagents and solvents used, test procedure applied, calculations made, results and any other relevant information or comments. 56
  • 57.
     Definitions  Validationof an Analytical Procedure: The documented process by which an analytical procedure (or method) is demonstrated to be suitable for its intended use.  Verification of an Analytical Procedure: Process by which a pharmacopeial method or validated analytical procedure is demonstrated to be suitable for the analysis to be performed.  Verification of Performance: Test procedure regularly applied to a system (e.g. liquid chromatographic system) to demonstrate consistency of response. 57
  • 58.
     What isa measurement? • A measurement tells us about a property of something. It might tell us how heavy an object is, or how hot, or how long it is. A measurement gives a number to that property. • Measurements are always made using an instrument of some kind (e.g., rulers, stopwatches, weighing scales and thermometers). • The result of a measurement is normally in two parts: 1) a number and 2) a unit of measurement (e.g., How long is something? 2 meters).  What is NOT a measurement? • There are some processes that might seem to be measurements, but are not. For example, comparing two pieces of string to see which is longer is not a measurement. Counting is not a measurement. Often, a test is not a measurement, tests normally lead to a yes/no answer or a pass/fail result. However, measurements may be part of the process leading up to a test result.  It is important not to confuse the terms ‘error’ and ‘uncertainty’. • Error is the difference between the measured value and the true value of the thing being measured. • Uncertainty is a quantification of the doubt about the measurement result. E l a b o r a t i o n s 58
  • 59.
     What isuncertainty of measurement? • Uncertainty of measurement is the doubt that exists about the result of any measurement. Meaning: You might think that well-made rulers, clocks and thermometers should be trustworthy, and give the right answers. But for every measurement, even the most careful, there is always a margin of doubt. This might be expressed as ‘give or take’ (e.g., a ruler might be two meters long ‘give or take’ a centimeter).  How to express uncertainty of measurement? • Since there is always a margin of doubt about any measurement, we need to ask (1) How big is the margin? and (2) How bad is the doubt?. • Thus, two numbers are really needed in order to quantify an uncertainty. One is the width of the margin, or an interval. The other is a confidence level, it states how sure we are that the ‘true value’ is within that margin. • For example:  We might say that the length of a certain ruler measures 20 centimeters plus or minus 1 centimeter, at the 95 percent confidence level.  This result will be written as such: 20cm ± 1cm, at a level of confidence of 95%.  The statement says that we are 95 percent sure that the stick is between 19 centimeters and 21 centimeters long. E l a b o r a t i o n s 59
  • 60.
    Reference © World HealthOrganization WHO Technical Report Series, No. 957, 2010 60